I Know, I Saw That, I am sure Everyone will be All Ears During that Presentation ! The Possibilities are Endless I Would Assume Most Current Diagnostic Testing is Done in 2-D ! Never Sell PSTI ! I Wonder if they Have Already Been Approached By the Big Diagnostic Companies For Potential Licensing Deals ??? Less
Sentiment: Strong Buy
-
1 Reply to allo_geneic
-
3rd Annual Cell-Based Assays Conference ! In London April 14-16, 2014 !
.
London, UK, April 14-16, 2014
Harnessing enabling technologies and platforms for drug discovery, development, toxicity testing & disease modelling
For every million compounds screened, approximately 250 make it to pre-clinical testing, 10 to clinical trials and just one is approved for patient use. Industry can ill-afford to continue such a wasteful process.
Cancerous and animal cells (many having been in continuous culture for decades), poorly reflect patient physiology. Finally, these are yielding to more representative models that better reflect the intended recipients of new molecular entities. Advances in label-free technologies, human primary, 3D assays and stem cell-derived lines are driving a paradigm shift in drug discovery, development, disease modelling and toxicity testing Less
